Synthesis of a Novel Siliconized Analog of Clofibrate (Silafibrate) and Comparison of their Anti-inflammatory Activities

AuthorMojtaba Ziaeeen
AuthorMorteza Saminien
AuthorMohammad Bolourtchianen
AuthorMohammad Ghaffarzadehen
AuthorMaryam Ahmadien
AuthorMohammad Ali Egbalen
AuthorArash Khorramien
AuthorSina Andaliben
AuthorNasrin Maleki-Dizajien
AuthorAlireza Garjanien
Issued Date2012-01-31en
AbstractFibrates, as hypolipidemic drugs known as agonists of peroxisome proliferator-activated receptors, diminish inflammatory responses. Studies have shown that incorporation of a silicon atom into a drug structure improves its pharmacological potency, modifies its selectivity toward a given target, or changes its metabolic rate, in addition to increasing the lipophilicity of the compounds. A siliconized analog of clofibrate, ethyl-2-methyl-2-(4-(trimethylsilyl)phenoxy)propionate was synthesized, whereby the chlorine atom in the phenoxy ring was replaced by a trimethylsilyl group. The anti-inflammatory effects of the siliconized analog (silafibrate) were evaluated in an air-pouch model of inflammation and compared with those of clofibrate. Oral administration of both drugs produced a significant anti-inflammatory action by reducing carrageenan induced pouch leukocyte recruitment, exudates production, and granulated tissue weight. The silicon isostere of clofibrate has improved anti-inflammatory properties.en
DOIhttps://doi.org/10.22037/ijpr.2011.1045en
URIhttps://brieflands.com/journals/ijpr/articles/125767en
KeywordClofibrateen
KeywordSiliconen
KeywordSiliconized analogen
KeywordAnti-inflammatoryen
PublisherBrieflandsen
TitleSynthesis of a Novel Siliconized Analog of Clofibrate (Silafibrate) and Comparison of their Anti-inflammatory Activitiesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IJPR-011-091.pdf
Size:
409.57 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF